Clinical Trials Logo

Clinical Trial Summary

The telavancin observational use registry (TOUR) will collect data to support study of the efficacy, safety, and pattern of use of telavancin in hospital-based inpatients and in outpatients being treated in infusion centers who are receiving clinician directed telavancin therapy.


Clinical Trial Description

This is a retrospective medical chart review, multicenter, observational study to examine telavancin efficacy and safety in a real-word setting and to characterize the pattern of use of telavancin in hospital-based inpatients and in outpatient infusion centers. All treatment decisions and clinical assessment will be made at the discretion of the treating physician per usual care and are not mandated by study design or protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02288234
Study type Observational
Source Cumberland Pharmaceuticals
Contact
Status Completed
Phase
Start date November 2014
Completion date October 2017

See also
  Status Clinical Trial Phase
Completed NCT01072539 - Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Completed NCT01128530 - Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) Phase 2
Completed NCT00683332 - Post-Marketing Study Of The Safety Of Tygacil (Tigecycline) N/A
Terminated NCT01104662 - Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment Phase 4